Skip to main content
  1. Courses
  2. Dermatopathology in the Des...

Dermatopathology in the Desert: Dodging Bullets in the Dermatopathology Wilderness



Original release date: September 27, 2021
Access to this course expires on:  September 10, 2024 at 11:59 PM Pacific Time
CME 12.25

Course Description
Differentiating neoplastic from non-neoplastic disorders is one of the most difficult diagnostic challenges in pathology. Accurate diagnosis is paramount to initiate the appropriate treatment. It requires specific skills which often include at least some degree of clinical knowledge, awareness of the broad morphologic range and familiarity with ancillary tests. Errors in the interpretation of skin biopsies, especially in relation to melanocytic tumours, are among the most frequent causes for litigation in surgical biopsy and can lead to unfavorable patient outcomes. There are numerous pitfalls that diagnostic pathologists need to be aware of, including lack of relevant clinical information, sampling error and the wide morphologic spectrum of both inflammatory and neoplastic disorder, often showing overlapping findings and only subtle differentiating features.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Understand the wide morphologic spectrum of cutaneous tumors and associated diagnostic challenges
  • Learn about recent developments in dermatopathology
  • Learn how to integrate clinical information and ancillary tests to achieve a better and more precise diagnosis
  • Understand the appropriate use and limitations of immunofluorescence testing in dermatopathology

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. USCAP has reviewed the disclosures and mitigated all relevant financial relationships.

The following faculty reported no relevant financial relationships: Thomas Brenn, MD, PhD, FRCPath, Scott Binder, MD, Julia Lehman, MD, Iwei Yeh, MD, PhD

The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Steven D. Billings, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. View and print your certificate by  clicking here.

Buy the entire Dermatopathology in the Desert course and get a great discount! 

Not A Member? Click Here